Join

Compare · NMRD vs SYK

NMRD vs SYK

Side-by-side comparison of Nemaura Medical Inc. (NMRD) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both NMRD and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • SYK is the larger of the two at $115.59B, about 1268.6x NMRD ($91.1M).
  • SYK has hit the wire 8 times in the past 4 weeks while NMRD has been quiet.
  • SYK has more recent analyst coverage (25 ratings vs 2 for NMRD).
MetricNMRDSYK
Company
Nemaura Medical Inc.
Stryker Corporation
Price
$0.12-5.38%
$311.77+3.37%
Market cap
$91.1M
$115.59B
1M return
-
+9.19%
1Y return
-
-18.42%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
News (4w)
0
8
Recent ratings
2
25
NMRD

Nemaura Medical Inc.

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.

SYK

Stryker Corporation

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Latest NMRD

Latest SYK